BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/13/2018 7:26:52 AM | Browse: 1509 | Download: 2180
 |
Received |
|
2018-08-27 01:28 |
|
Peer-Review Started |
|
2018-08-27 01:55 |
|
First Decision by Editorial Office Director |
|
2018-10-04 13:24 |
|
Return for Revision |
|
2018-10-09 01:24 |
|
Revised |
|
2018-10-24 22:41 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2018-11-23 11:02 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2018-11-26 16:46 |
|
Articles in Press |
|
2018-11-26 16:46 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-12-07 06:53 |
|
Publish the Manuscript Online |
|
2018-12-13 07:26 |
| ISSN |
2150-5349 (online) |
| Open Access |
There have been tremendous changes in the treatment of acid-related diseases. In this rapidly evolving field, novel drugs such as potassium-competitive acid blockers (P-CABs) show promising potential. This review aims to provide a perspective on this new class of drugs by summarizing the mechanism of action, therapeutic benefits, adverse effects and approval status of various P-CABs in the market. |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Potassium-competitive acid blockers – are they the next generation of proton pump inhibitors?
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Prashanth Rawla, Tagore Sunkara, Andrew Ofosu and Vinaya Gaduputi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Prashanth Rawla, MD, Doctor, Doctor, Staff Physician, Department of Internal Medicine/Hospitalist, SOVAH Health, 320 Hospital Dr, Martinsville, VA 24112, United States. rawlap@gmail.com |
| Key Words |
Potassium-competitive acid blockers; Gastroesophageal reflux disease; Proton pump inhibitors; Peptic ulcer disease; Vonoprazan |
| Core Tip |
There have been tremendous changes in the treatment of acid-related diseases. In this rapidly evolving field, novel drugs such as potassium-competitive acid blockers (P-CABs) show promising potential. This review aims to provide a perspective on this new class of drugs by summarizing the mechanism of action, therapeutic benefits, adverse effects and approval status of various P-CABs in the market. |
| Publish Date |
2018-12-13 07:26 |
| Citation |
Rawla P, Sunkara T, Ofosu A, Gaduputi V. Potassium-competitive acid blockers – are they the next generation of proton pump inhibitors? World J Gastrointest Pharmacol Ther 2018; 9(7): 63-68 |
| URL |
https://www.wjgnet.com/2150-5349/full/v9/i7/63.htm |
| DOI |
https://dx.doi.org/10.4292/wjgpt.v9.i7.63 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
